Gregory A Grandits

1984 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 6 Similar Profiles
Coronary Disease Medicine & Life Sciences
Blood Pressure Medicine & Life Sciences
Hypertension Medicine & Life Sciences
HIV Medicine & Life Sciences
Cardiovascular Diseases Medicine & Life Sciences
Antihypertensive Agents Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2007 2016

Research Output 1984 2019

PreVail I cluster vaccination study with RVSVDG-Zebov-GP as part of a public health response in Liberia

Bolay, F. K., Grandits, G., Clifford Lane, H., Kennedy, S. B., Johnson, M. P., Fallah, M. P., Wilson, B., Njoh, W. S., McNay, L. A., Hensley, L. E. & Higgs, E. S., May 1 2019, In : Journal of Infectious Diseases. 219, 10, p. 1634-1641 8 p.

Research output: Contribution to journalArticle

Open Access
Liberia
Ebola Hemorrhagic Fever
Vaccination
Public Health
Ebola Vaccines
1 Citation (Scopus)

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

Kaptoge, S., Pennells, L., De Bacquer, D., Cooney, M. T., Kavousi, M., Stevens, G., Riley, L. M., Savin, S., Khan, T., Altay, S., Amouyel, P., Assmann, G., Bell, S., Ben-Shlomo, Y., Berkman, L., Beulens, J. W., Björkelund, C., Blaha, M., Blazer, D. G., Bolton, T. & 81 others, Bonita Beaglehole, R., Brenner, H., Brunner, E. J., Casiglia, E., Chamnan, P., Choi, Y. H., Chowdry, R., Coady, S., Crespo, C. J., Cushman, M., Dagenais, G. R., D'Agostino, R. B., Daimon, M., Davidson, K. W., Engström, G., Ford, I., Gallacher, J., Gansevoort, R. T., Gaziano, T. A., Giampaoli, S., Grandits, G., Grimsgaard, S., Grobbee, D. E., Gudnason, V., Guo, Q., Tolonen, H., Humphries, S., Iso, H., Jukema, J. W., Kauhanen, J., Kengne, A. P., Khalili, D., Koenig, W., Kromhout, D., Krumholz, H., Lam, T. H., Laughlin, G., Marín Ibañez, A., Meade, T. W., Moons, K. G. M., Nietert, P. J., Ninomiya, T., Nordestgaard, B. G., O'Donnell, C., Palmieri, L., Patel, A., Perel, P., Price, J. F., Providencia, R., Ridker, P. M., Rodriguez, B., Rosengren, A., Roussel, R., Sakurai, M., Salomaa, V., Sato, S., Schöttker, B., Shara, N., Shaw, J. E., Shin, H. C., Simons, L. A., Sofianopoulou, E., Sundström, J., Völzke, H., Wallace, R. B., Wareham, N. J., Willeit, P., Wood, D., Wood, A., Zhao, D., Woodward, M., Danaei, G., Roth, G., Mendis, S., Onuma, O., Varghese, C., Ezzati, M., Graham, I., Jackson, R., Danesh, J. & Di Angelantonio, E., Oct 2019, In : The Lancet Global Health. 7, 10, p. e1332-e1345

Research output: Contribution to journalArticle

Open Access
Cardiovascular Diseases
Blood Pressure
Stroke
Myocardial Infarction
Cholesterol

A review of strategies used to retain participants in clinical research during an infectious disease outbreak: The PREVAIL I Ebola vaccine trial experience

Browne, S., Carter, T., Eckes, R., Grandits, G. A., Johnson, M., Moore, I. & McNay, L., Sep 1 2018, In : Contemporary Clinical Trials Communications. 11, p. 50-54 5 p.

Research output: Contribution to journalArticle

Open Access
Ebola Vaccines
Disease Outbreaks
Vaccines
Liberia
Research
5 Citations (Scopus)

Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay

Logue, J., Tuznik, K., Follmann, D., Grandits, G., Marchand, J., Reilly, C., Sarro, Y. D. S., Pettitt, J., Stavale, E. J., Fallah, M., Olinger, G. G., Bolay, F. K. & Hensley, L. E., May 2018, In : Journal of Virological Methods. 255, p. 84-90 7 p.

Research output: Contribution to journalArticle

Ebolavirus
Ebola Hemorrhagic Fever
Social Planning
Disease Outbreaks
Survivors
15 Citations (Scopus)

Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial

INSIGHT (International Network for Strategic Initiatives in Global HIV Trials) START (Strategic Timing of Antiretroviral Treatment) Study Group, May 22 2017, In : Journal of the American Heart Association. 6, 5

Research output: Contribution to journalArticle

Open Access
Cardiovascular Diseases
HIV
HDL Cholesterol
Cholesterol
LDL Cholesterol